These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37284101)

  • 1. Diagnostic and prognostic performance of renal compartment volume and the apparent diffusion coefficient obtained from magnetic resonance imaging in mild, moderate and severe diabetic kidney disease.
    Zhao K; Li S; Liu Y; Li Q; Lin H; Wu Z; Seeliger E; Niendorf T; Liu Z; Wang W
    Quant Imaging Med Surg; 2023 Jun; 13(6):3973-3987. PubMed ID: 37284101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of the corticomedullary difference in magnetic resonance imaging-derived apparent diffusion coefficient for noninvasive assessment of chronic kidney disease in type 2 diabetes.
    Duan S; Geng L; Lu F; Chen C; Jiang L; Chen S; Zhang C; Huang Z; Zeng M; Sun B; Zhang B; Mao H; Xing C; Zhang Y; Yuan Y
    Diabetes Metab Syndr; 2024 Feb; 18(2):102963. PubMed ID: 38373384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion kurtosis imaging as an imaging biomarker for predicting prognosis in chronic kidney disease patients.
    Liu Y; Zhang GM; Peng X; Li X; Sun H; Chen L
    Nephrol Dial Transplant; 2022 Jul; 37(8):1451-1460. PubMed ID: 34302484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-magnetic resonance imaging predicts decline of kidney function in chronic kidney disease and in patients with a kidney allograft.
    Berchtold L; Crowe LA; Combescure C; Kassaï M; Aslam I; Legouis D; Moll S; Martin PY; de Seigneux S; Vallée JP
    Kidney Int; 2022 Apr; 101(4):804-813. PubMed ID: 35031327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol.
    Gooding KM; Lienczewski C; Papale M; Koivuviita N; Maziarz M; Dutius Andersson AM; Sharma K; Pontrelli P; Garcia Hernandez A; Bailey J; Tobin K; Saunavaara V; Zetterqvist A; Shelley D; Teh I; Ball C; Puppala S; Ibberson M; Karihaloo A; Metsärinne K; Banks RE; Gilmour PS; Mansfield M; Gilchrist M; de Zeeuw D; Heerspink HJL; Nuutila P; Kretzler M; Welberry Smith M; Gesualdo L; Andress D; Grenier N; Shore AC; Gomez MF; Sourbron S;
    BMC Nephrol; 2020 Jun; 21(1):242. PubMed ID: 32600374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the corticomedullary difference in magnetic resonance imaging-derived apparent diffusion coefficient for kidney fibrosis detection: a cross-sectional study.
    Berchtold L; Friedli I; Crowe LA; Martinez C; Moll S; Hadaya K; de Perrot T; Combescure C; Martin PY; Vallée JP; de Seigneux S
    Nephrol Dial Transplant; 2020 Jun; 35(6):937-945. PubMed ID: 30608554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive Assessment of Diabetic Kidney Disease With MRI: Hype or Hope?
    Zhao K; Seeliger E; Niendorf T; Liu Z
    J Magn Reson Imaging; 2024 May; 59(5):1494-1513. PubMed ID: 37675919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney Functional Magnetic Resonance Imaging and Change in eGFR in Individuals with CKD.
    Srivastava A; Cai X; Lee J; Li W; Larive B; Kendrick C; Gassman JJ; Middleton JP; Carr J; Raphael KL; Cheung AK; Raj DS; Chonchol MB; Fried LF; Block GA; Sprague SM; Wolf M; Ix JH; Prasad PV; Isakova T
    Clin J Am Soc Nephrol; 2020 Jun; 15(6):776-783. PubMed ID: 32345747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
    Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
    Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of quantitative contrast-enhanced ultrasound (CEUS) for early detection of renal hyperperfusion in diabetic kidney disease.
    Wang L; Wu J; Cheng JF; Liu XY; Ma F; Guo LH; Xu JM; Wu T; Mohan C; Peng A; Xu HX; Song YX
    J Nephrol; 2015 Dec; 28(6):669-78. PubMed ID: 25712236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of the natural history of diabetic kidney disease (DKD).
    Altemtam N; Russell J; El Nahas M
    Nephrol Dial Transplant; 2012 May; 27(5):1847-54. PubMed ID: 22058177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary soluble CD90 predicts renal prognosis in patients with diabetic kidney disease.
    Wu L; Chang DY; Zhang LX; Chen M; Zhao MH
    Ann Transl Med; 2021 Feb; 9(4):282. PubMed ID: 33708909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Keluoxin capsule combined with losartan potassium on diabetic kidney disease: study protocol for a randomized double-blind placebo-controlled multicenter clinical trial.
    Wu R; Wei F; Qu L; Bai L; Li J; Li F; Yan W; Wang Q; Wei J
    Trials; 2020 Nov; 21(1):951. PubMed ID: 33228726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study.
    Yamanouchi M; Furuichi K; Shimizu M; Toyama T; Yamamura Y; Oshima M; Kitajima S; Hara A; Iwata Y; Sakai N; Oba Y; Matsuoka S; Ikuma D; Mizuno H; Suwabe T; Hoshino J; Sawa N; Yuzawa Y; Kitamura H; Suzuki Y; Sato H; Uesugi N; Ueda Y; Nishi S; Yokoyama H; Nishino T; Samejima K; Kohagura K; Shibagaki Y; Makino H; Matsuo S; Ubara Y; Wada T
    Nephrol Dial Transplant; 2022 Feb; 37(3):489-497. PubMed ID: 34028524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological assessment of chronic kidney disease with DWI: Is there an added value for diffusion kurtosis imaging?
    Mao W; Ding Y; Ding X; Wang Y; Fu C; Zeng M; Zhou J
    J Magn Reson Imaging; 2021 Aug; 54(2):508-517. PubMed ID: 33634937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing renal interstitial fibrosis using compartmental, non-compartmental, and model-free diffusion MRI approaches.
    Hu W; Dai Y; Liu F; Yang T; Wang Y; Shen Y; Zhou W; Wu D; Gu L; Zhang M; Zhou Y
    Insights Imaging; 2024 Jun; 15(1):156. PubMed ID: 38900336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial spin labeling and diffusion-weighted MR imaging: quantitative assessment of renal pathological injury in chronic kidney disease.
    Pi S; Li Y; Lin C; Li G; Wen H; Peng H; Wang J
    Abdom Radiol (NY); 2023 Mar; 48(3):999-1010. PubMed ID: 36598569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of triglyceride and cystatin C ratio in diabetic kidney disease: a retrospective and prospective cohort study based on renal biopsy.
    Wei J; Wang B; Shen FJ; Zhang TT; Duan Z; Zhou DM
    BMC Nephrol; 2022 Jul; 23(1):270. PubMed ID: 35896961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced oxygenation but not fibrosis defined by functional magnetic resonance imaging predicts the long-term progression of chronic kidney disease.
    Sugiyama K; Inoue T; Kozawa E; Ishikawa M; Shimada A; Kobayashi N; Tanaka J; Okada H
    Nephrol Dial Transplant; 2020 Jun; 35(6):964-970. PubMed ID: 30418615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted MR volume and apparent diffusion coefficient for discriminating lymph node metastases and good response after chemoradiation therapy in locally advanced rectal cancer.
    Yuan Y; Pu H; Chen GW; Chen XL; Liu YS; Liu H; Wang K; Li H
    Eur Radiol; 2021 Jan; 31(1):200-211. PubMed ID: 32740816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.